Results 171 to 180 of about 500,835 (209)

Therapeutic Efficacy of Melanoma-Reactive TIL Injected in Stage III Melanoma Patients

Cancer Immunology, Immunotherapy, 2002
Brigitte Dréno, Amir Khammari, Nadine Gervois   +2 more
exaly  

PD-L1 in Combination With CD8⁺TIL and HIF-1α Are Promising Prognosis Predictors of Head and Neck Squamous Cell Carcinoma

Cancer Management and Research, 2020
Xianbin Zhang, Xingchen Ding, Man Hu
exaly  

Antigen-Specific TIL Therapy for Melanoma: A Flexible Platform for Personalized Cancer Immunotherapy

European Journal of Immunology, 2016
John B A G Haanen, Mireille Toebes, Pia Kvistborg   +2 more
exaly  

Tekstredegørelse til "Til publikum!"

2012
Thaulow, Vanja, Berg, Holger
openaire   +1 more source

Cul-TIL-Vating Uveal Melanoma Regression

Nature Reviews Clinical Oncology, 2017
Lisa Hutchinson
exaly  

TIL

2008
openaire   +2 more sources

Efficacy of TIL Therapy in Advanced Cutaneous Melanoma in the Current Immuno-Oncology Era: Updated Systematic Review and Meta-Analysis

Annals of Oncology
John B A G Haanen, Silvia Martín-Lluesma, Dimitris Karlis   +2 more
exaly  

Predictive Relevance of PD-L1 Expression Combined With CD8+ TIL Density in Stage III Non-Small Cell Lung Cancer Patients Receiving Concurrent Chemoradiotherapy

European Journal of Cancer, 2016
Tomoaki Hoshino, Akihiko Kawahara, Norikazu Matsuo   +2 more
exaly  

Shopping 'Til We Drop

Lancet, The, 2004
exaly  

Design til kontoret

2016
Stockmarr, Pernille, Petersen, Trine Brun   +1 more
openaire   +2 more sources